|
ZNF107 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.52582999999318E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.52459999999533E-05 |
| Normal-vs-Stage2 |
6.619400E-03 |
| Normal-vs-Stage3 |
1.84629999999686E-06 |
| Normal-vs-Stage4 |
3.183800E-03 |
| Stage1-vs-Stage2 |
8.394400E-01 |
| Stage1-vs-Stage3 |
2.198600E-01 |
| Stage1-vs-Stage4 |
8.186400E-01 |
| Stage2-vs-Stage3 |
3.088600E-01 |
| Stage2-vs-Stage4 |
7.472200E-01 |
| Stage3-vs-Stage4 |
6.041200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.42239999995275E-06 |
| Normal-vs-AfricanAmerican |
3.972600E-01 |
| Normal-vs-Asian |
6.315900E-02 |
| Caucasian-vs-AfricanAmerican |
7.389600E-02 |
| Caucasian-vs-Asian |
1.205970E-01 |
| AfricanAmerican-vs-Asian |
6.145800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.425300E-04 |
| Normal-vs-Female |
2.41539999999985E-05 |
| Male-vs-Female |
7.584800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.584900E-04 |
| Normal-vs-Age(41-60Yrs) |
1.76456999999575E-05 |
| Normal-vs-Age(61-80Yrs) |
2.953800E-04 |
| Normal-vs-Age(81-100Yrs) |
6.763800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.292000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.715000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.150800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.566800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.945200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.270000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.033900E-02 |
| Classical-VS-Follicular |
4.762600E-03 |
| Classical-VS-Other |
6.357600E-01 |
| Classical-VS-Normal |
1.018140E-03 |
| Tall-VS-Follicular |
7.765000E-01 |
| Tall-VS-Other |
6.752600E-01 |
| Tall-VS-Normal |
6.03699999999208E-05 |
| Follicular-VS-Other |
6.266200E-01 |
| Follicular-VS-Normal |
6.30519999988977E-07 |
| Other-VS-Normal |
6.067800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.00419999999424E-05 |
| Normal-vs-N1 |
1.621980E-02 |
| N0-vs-N1 |
3.384000E-01 |
|
|
